FY2029 Earnings Estimate for REVB Issued By Roth Capital
Revelation Biosciences, Inc. (NASDAQ:REVB – Free Report) – Stock analysts at Roth Capital issued their FY2029 earnings per share (EPS) estimates for shares of Revelation Biosciences in a research report issued to clients and investors on Friday, March 7th. Roth Capital analyst J. Aschoff forecasts that the company will earn $2.23 per share for the […]
